Author:
Myden Alun,Cayley Alex,Davies Robert,Jones Jade,Kane Steven,Newman Daniel,Payne Martin P.,Ude Victor C.,Vessey Jonathan D.,White Emma,Fowkes Adrian
Funder
National Institute of Health Sciences
Reference55 articles.
1. History and evolution of reproductive and developmental toxicology guidelines;Collins;Curr. Pharm. Des.,2006
2. EMA/CHMP/ICH/544278/1998, ICH S5 (R3) guideline on reproductive toxicology: Detection of toxicity to reproduction for human pharmaceuticals, 2020. https://www.ema.europa.eu/en/ich-s5-r3-guideline-reproductive-toxicology-detection-toxicity-reproduction-human-pharmaceuticals.
3. Reproductive and developmental toxicity testing: from in vivo to in vitro;Stallman Brown;ALTEX.,2012
4. Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation;Chapman;Regul. Toxicol. Pharmacol.,2013
5. Alternative models of developmental and reproductive toxicity in pharmaceutical risk assessment and the 3Rs;Brannen;ILAR J.,2016